日本糖尿病設備市場報告（按類型（管理設備、監測設備）、配銷通路（醫院藥房、零售藥房、糖尿病診所/中心、線上藥房及其他）和地區分類，2026-2034 年）

Japan Diabetes Devices Market Report by Type (Management Devices, Monitoring Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, and Others), and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本糖尿病設備市場規模達19.902億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到25.206億美元，2026年至2034年期間的複合年成長率（CAGR）為2.66%。推動市場成長的主要動力來自於旨在滿足糖尿病管理、監測和治療多方面需求的重大創新和技術進步。

本報告解答的關鍵問題：

日本糖尿病設備市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本糖尿病設備市場產生了哪些影響？
日本糖尿病設備市場按類型分類的組成是怎樣的？
日本糖尿病設備市場按配銷通路分類的組成是怎樣的？
日本糖尿病設備市場價值鏈的各個階段有哪些？
日本糖尿病醫療器材產業的關鍵促進因素和挑戰是什麼？
日本糖尿病醫療器材市場的結構是怎麼樣的？主要參與者有哪些？
日本糖尿病醫療器材市場的競爭程度如何？

Japan diabetes devices market size reached USD 1,990.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,520.6 Million by 2034, exhibiting a growth rate (CAGR) of 2.66% during 2026-2034. Significant innovations and technological advancements, focused on addressing the multifaceted demands of diabetic management, monitoring, and treatment are primarily driving the market growth.

Diabetes devices refer to a category of medical equipment specifically designed to manage, monitor, and treat diabetes, a chronic condition characterized by elevated blood sugar levels. These devices play an essential role in assisting individuals with diabetes to maintain optimal blood glucose levels and prevent complications associated with uncontrolled diabetes. Diabetes devices include blood glucose monitors, insulin pumps, insulin pens, and continuous glucose monitoring (CGM) systems, amongst others. Blood glucose monitors are utilized for intermittent blood sugar testing, while the latter provide real-time glucose readings throughout the day. Insulin pumps and pens are crucial for the delivery of insulin, a hormone essential for the metabolism of carbohydrates, fats, and proteins. These devices, with their advancements in technology, are becoming more user-friendly, accurate, and minimally invasive, catering to the specific needs and preferences of diabetic patients. The incorporation of digital technologies such as apps and telemedicine platforms also helps in better diabetes management by offering personalized care and remote monitoring capabilities. In essence, diabetes devices are pivotal in empowering individuals with diabetes to lead a healthier and more manageable life, fostering advancements in medical technology and healthcare.

Japan Diabetes Devices Market Trends:

The Japan diabetes devices market is witnessing a period of substantial growth, driven by a confluence of trends and drivers, including an aging population and increasing prevalence of diabetes within the country. With Japan being home to a considerable elderly demographic, the necessity for innovative and efficient diabetes management devices is more paramount than ever, propelling advancements and investments in this sector. The surge in health consciousness and self-management of diabetes is leading to increased demand for user-friendly, accurate, and technologically advanced devices, such as continuous glucose monitoring systems and insulin delivery devices. Technological innovations and the integration of IoT and AI are significant trends in the market, enhancing the functionalities of diabetes devices, offering real-time monitoring, data analysis, and personalized recommendations, thus elevating the standard of diabetes care. The government's supportive policies and initiatives aimed at healthcare innovation and chronic disease management also act as catalysts, bolstering the market's trajectory. Moreover, the rise in partnerships between tech companies and medical device manufacturers is fostering the development of more sophisticated solutions. The growing acceptance and adoption of these advanced diabetes devices among healthcare providers and patients are anticipated to further augment the market growth. The emphasis on minimally invasive or non-invasive devices and the proliferation of telehealth and remote monitoring are reshaping the landscape of diabetes management in Japan, indicating a promising future for the diabetes devices market in the region.

Japan Diabetes Devices Market Segmentation:

Type Insights:

Management Devices
- Insulin Pump
- Insulin Syringes
- Cartridges in Reusable Pens
- Insulin Disposable Pens
- Jet Injectors
Monitoring Devices
- Self-monitoring Blood Glucose
- Continuous Glucose Monitoring

Distribution Channel Insights:

Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

ARKRAY Inc.
Ascensia Diabetes Care Holdings AG
Dexcom Inc.
Terumo Corporation

Key Questions Answered in This Report:

How has the Japan diabetes devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan diabetes devices market?
What is the breakup of the Japan diabetes devices market on the basis of type?
What is the breakup of the Japan diabetes devices market on the basis of distribution channel?
What are the various stages in the value chain of the Japan diabetes devices market?
What are the key driving factors and challenges in the Japan diabetes devices?
What is the structure of the Japan diabetes devices market and who are the key players?
What is the degree of competition in the Japan diabetes devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Diabetes Devices Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Diabetes Devices Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Diabetes Devices Market - Breakup by Type

6.1 Management Devices
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Insulin Pump
  - 6.1.3.2 Insulin Syringes
  - 6.1.3.3 Cartridges in Reusable Pens
  - 6.1.3.4 Insulin Disposable Pens
  - 6.1.3.5 Jet Injectors
- 6.1.4 Market Forecast (2026-2034)
6.2 Monitoring Devices
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Self-monitoring Blood Glucose
  - 6.2.3.2 Continuous Glucose Monitoring
- 6.2.4 Market Forecast (2026-2034)

7 Japan Diabetes Devices Market - Breakup by Distribution Channel

7.1 Hospital Pharmacies
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Retail Pharmacies
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Diabetes Clinics/Centers
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Online Pharmacies
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2020-2025)
- 7.5.2 Market Forecast (2026-2034)

8 Japan Diabetes Devices Market - Breakup by Region

8.1 Kanto Region
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Breakup by Type
- 8.1.4 Market Breakup by Distribution Channel
- 8.1.5 Key Players
- 8.1.6 Market Forecast (2026-2034)
8.2 Kansai/Kinki Region
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Breakup by Type
- 8.2.4 Market Breakup by Distribution Channel
- 8.2.5 Key Players
- 8.2.6 Market Forecast (2026-2034)
8.3 Central/ Chubu Region
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Breakup by Type
- 8.3.4 Market Breakup by Distribution Channel
- 8.3.5 Key Players
- 8.3.6 Market Forecast (2026-2034)
8.4 Kyushu-Okinawa Region
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Breakup by Type
- 8.4.4 Market Breakup by Distribution Channel
- 8.4.5 Key Players
- 8.4.6 Market Forecast (2026-2034)
8.5 Tohoku Region
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Breakup by Type
- 8.5.4 Market Breakup by Distribution Channel
- 8.5.5 Key Players
- 8.5.6 Market Forecast (2026-2034)
8.6 Chugoku Region
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Breakup by Type
- 8.6.4 Market Breakup by Distribution Channel
- 8.6.5 Key Players
- 8.6.6 Market Forecast (2026-2034)
8.7 Hokkaido Region
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Breakup by Type
- 8.7.4 Market Breakup by Distribution Channel
- 8.7.5 Key Players
- 8.7.6 Market Forecast (2026-2034)
8.8 Shikoku Region
- 8.8.1 Overview
- 8.8.2 Historical and Current Market Trends (2020-2025)
- 8.8.3 Market Breakup by Type
- 8.8.4 Market Breakup by Distribution Channel
- 8.8.5 Key Players
- 8.8.6 Market Forecast (2026-2034)

9 Japan Diabetes Devices Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 ARKRAY Inc.
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Ascensia Diabetes Care Holdings AG
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Dexcom Inc.
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Terumo Corporation
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events

11 Japan Diabetes Devices Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis